KHRNF (Khiron Life Sciences) Cyclically Adjusted Book per Share: $0.24 (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Khiron Life Sciences Cyclically Adjusted Book per Share?

Khiron Life Sciences KHRNF -90.00% Cyclically Adjusted Book per Share is $0.24 as of Sep. 2022.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Khiron Life Sciences's adjusted book value per share for the three months ended in Sep. 2022 was $0.094. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.24 for the trailing ten years ended in Sep. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-01), Khiron Life Sciences's current stock price is $1.0E-5. Khiron Life Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2022 was $0.24. Khiron Life Sciences's Cyclically Adjusted PB Ratio of today is 0.00.


Khiron Life Sciences  (OTCPK:KHRNF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Khiron Life Sciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.0E-5/0.24
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Khiron Life Sciences Cyclically Adjusted Book per Share Related Terms


Khiron Life Sciences Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Khiron Life Sciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Khiron Life Sciences Cyclically Adjusted Book per Share Chart

Khiron Life Sciences Annual Data
Trend May12 May13 May14 May15 May16 May17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Khiron Life Sciences Quarterly Data
Nov17 Feb18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.27 0.26 0.24

KHRNF vs ZTS, CTLT, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Khiron Life Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Khiron Life Sciences Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Khiron Life Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Khiron Life Sciences's Cyclically Adjusted PB Ratio falls into.



Khiron Life Sciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Khiron Life Sciences's adjusted Book Value per Share data for the three months ended in Sep. 2022 was:

Adj_Book= Book Value per Share /CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=0.094/120.6479*120.6479
=0.094

Current CPI (Sep. 2022) = 120.6479.

Khiron Life Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201211 1.122 96.313 1.405
201302 1.000 96.945 1.244
201305 0.902 97.182 1.120
201308 0.764 97.261 0.948
201311 0.673 97.182 0.836
201402 0.504 98.051 0.620
201405 0.386 99.394 0.469
201408 0.205 99.315 0.249
201411 0.098 99.078 0.119
201502 0.032 99.078 0.039
201505 0.179 100.263 0.215
201508 0.058 100.579 0.070
201511 0.021 100.421 0.025
201602 -0.005 100.421 -0.006
201605 -0.279 101.765 -0.331
201608 -0.337 101.686 -0.400
201611 -0.379 101.607 -0.450
201702 -0.426 102.476 -0.502
201705 -0.416 103.108 -0.487
201708 -0.130 103.108 -0.152
201711 0.150 103.740 0.174
201802 0.081 104.688 0.093
201806 0.109 105.557 0.125
201809 0.204 105.636 0.233
201812 0.253 105.399 0.290
201903 0.391 106.979 0.441
201906 0.589 107.690 0.660
201909 0.546 107.611 0.612
201912 0.456 107.769 0.510
202003 0.379 107.927 0.424
202006 0.362 108.401 0.403
202009 0.328 108.164 0.366
202012 0.328 108.559 0.365
202103 0.291 110.298 0.318
202106 0.275 111.720 0.297
202109 0.242 112.905 0.259
202112 0.145 113.774 0.154
202203 0.130 117.646 0.133
202206 0.111 120.806 0.111
202209 0.094 120.648 0.094

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.24 mean?
Khiron Life Sciences (KHRNF) has a Cyclically Adjusted Book per Share of $0.24 as of Sep. 2022. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Khiron Life Sciences and its competitors.
Is Khiron Life Sciences' Cyclically Adjusted Book per Share too high?
Khiron Life Sciences' current Cyclically Adjusted Book per Share is $0.24.
How does Khiron Life Sciences' Cyclically Adjusted Book per Share compare to ZTS and CTLT?
Khiron Life Sciences' Cyclically Adjusted Book per Share of $0.24 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Khiron Life Sciences and its competitors. Khiron Life Sciences's current Cyclically Adjusted Book per Share is $0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Khiron Life Sciences stock overvalued right now?
Khiron Life Sciences (KHRNF) has a current Cyclically Adjusted Book per Share of $0.24. The current Cyclically Adjusted Book per Share is $0.24. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Khiron Life Sciences (KHRNF), the current Cyclically Adjusted Book per Share is $0.24 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Khiron Life Sciences Business Description

Address 2300 - 500 Burrard Street, Vancouver, BC, CAN, V6C 2B5
Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.